Hantavirus Andes variant spreads person-to-person, but poses limited pandemic risk

At least three deaths confirmed on Antarctic cruise ship MV Hondius with additional confirmed cases and suspected patients under investigation.
Hantavirus is rare but brutal—not contagious, but lethal
The virus spreads inefficiently between people but kills 35-50% of those who develop cardiopulmonary syndrome.

En las aguas heladas del Antártico, un brote de hantavirus a bordo del buque MV Hondius ha recordado al mundo que algunos peligros biológicos no se miden por su velocidad de contagio, sino por su capacidad de matar. La variante Andes, documentada principalmente en Argentina y Chile, posee la rara capacidad de transmitirse entre personas, aunque solo bajo condiciones de contacto estrecho y prolongado. Sin vacuna, sin tratamiento específico y con una mortalidad que puede superar el 50%, este virus plantea una pregunta que la medicina aún no ha sabido responder del todo: ¿cómo prepararse para lo que llega despacio pero golpea con fuerza devastadora?

  • Al menos tres personas murieron a bordo del MV Hondius, con más casos confirmados y otros bajo investigación, encendiendo alarmas en la comunidad científica internacional.
  • Las redes sociales han amplificado la desinformación, generando pánico desproporcionado ante un virus que, a diferencia del COVID-19, se transmite de forma muy ineficiente entre humanos.
  • La ausencia total de vacuna o tratamiento específico convierte cada diagnóstico tardío en una sentencia potencialmente mortal, con tasas de letalidad de entre 35 y 50% una vez desarrollado el síndrome cardiopulmonar.
  • Los síntomas iniciales imitan una gripe común, lo que lleva a los pacientes a subestimar la enfermedad durante los días críticos previos al colapso respiratorio.
  • Especialistas insisten en que el diagnóstico temprano es la única herramienta real disponible, mientras los sistemas de salud buscan protocolos para identificar casos en contextos de exposición a roedores o contacto cercano con infectados.

El hantavirus pertenece a una familia de virus que normalmente salta de roedores a humanos a través del contacto con orina, saliva o heces contaminadas. Pero la variante Andes, identificada en los años noventa y documentada principalmente en Argentina y Chile, tiene una característica que la distingue del resto: puede transmitirse de persona a persona. Este hecho cobró nueva relevancia tras el brote registrado en el buque de expedición antártica MV Hondius, donde al menos tres personas fallecieron y se investigan casos adicionales.

La transmisión entre humanos, según la especialista en enfermedades infecciosas Nancy Sandoval, requiere contacto cercano, prolongado y exposición directa a secreciones respiratorias. Nada que se parezca a la facilidad con que circulan el COVID-19 o el resfriado común. Oscar Donis, jefe de epidemiología del Instituto Guatemalteco de Seguridad Social, subraya que el virus se propaga de manera ineficiente entre personas, y que su período de incubación —que puede extenderse hasta seis semanas— lo diferencia radicalmente de los patógenos que protagonizaron la última pandemia.

Lo que hace verdaderamente peligroso al hantavirus no es su contagiosidad, sino su letalidad. Cuando desencadena el síndrome cardiopulmonar, la mortalidad oscila entre el 35 y el 50%, según Iris Cazali, jefa de la unidad de enfermedades infecciosas del Hospital Roosevelt. No existe vacuna, no hay tratamiento específico y la medicina solo puede ofrecer cuidados de soporte a quienes enferman gravemente.

El problema central es el tiempo. Los primeros síntomas —fiebre alta, dolor muscular intenso, escalofríos y malestar general— aparecen entre tres y cinco días antes de que emerjan las dificultades respiratorias, y fácilmente se confunden con una gripe estacional. Para cuando el paciente busca atención médica de urgencia, la enfermedad suele haber avanzado de forma significativa. El largo período de incubación agrava el escenario: una persona infectada puede desconocer su estado durante semanas, exponiéndose y exponiendo a otros sin saberlo. El brote del MV Hondius es un recordatorio de que algunos virus no necesitan ser rápidos para ser devastadores.

Hantavirus belongs to a family of viruses that normally jump from rodents to humans through contact with contaminated urine, saliva, or feces. But one variant—discovered in the 1990s—can move from person to person, a fact that has drawn fresh scrutiny after an outbreak aboard the Antarctic expedition ship MV Hondius left at least three people dead, with additional confirmed cases and others under investigation.

The Andes variant, which has been documented primarily in Argentina and Chile, spreads between humans only under very specific circumstances. Nancy Sandoval, an infectious disease specialist and vice president of the Pan-American Association of Infectology, explains that transmission requires close, prolonged contact and direct exposure to respiratory secretions—saliva and other bodily fluids. This is fundamentally different from how the virus typically moves through populations. The World Health Organization has emphasized that the pandemic risk remains low, though misinformation has circulated widely on social media.

Oscar Donis, head of epidemiology at Guatemala's social security institute, underscores how much less contagious the Andes variant is compared to COVID-19 or the common cold. The virus spreads inefficiently between people, meaning it cannot replicate with the speed that characterized the SARS-CoV-2 pandemic. The incubation period alone tells part of the story: while COVID-19 typically shows symptoms within two weeks, hantavirus can take up to six weeks to manifest.

What makes hantavirus genuinely dangerous is not how easily it spreads but how lethal it is. The virus can trigger cardiopulmonary syndrome, a condition that damages the lungs and heart. Iris Cazali, an infectious disease physician and head of the infectious disease unit at Hospital Roosevelt, notes that mortality rates for this syndrome range between 35 and 50 percent. To put this in perspective: COVID-19 is far more contagious but much less deadly. Hantavirus inverts that equation entirely.

The family of hantavirus contains at least 38 known variants, of which 24 cause disease in humans. Yet despite decades of study since the virus was first identified, no vaccine exists, no specific treatment has been developed, and no cure is available for those infected. Early diagnosis becomes critical precisely because symptoms initially mimic ordinary flu—sudden high fever, intense muscle pain, chills, and general malaise, sometimes accompanied by nausea and abdominal pain. These early signs typically appear three to five days before respiratory difficulties emerge. By the time breathing problems develop, the disease has often progressed significantly, leaving doctors with supportive care as their primary tool.

Cazali emphasizes that the challenge lies in recognizing the disease before it advances. A patient might dismiss initial symptoms as seasonal illness, delaying the medical attention that could make the difference between survival and death. The long incubation period compounds this problem—someone could be infected for weeks without knowing it, potentially exposing others during that window. The outbreak on the MV Hondius serves as a stark reminder that even in our connected world, with all our medical knowledge, some viruses remain profoundly difficult to stop once they take hold.

The Andes variant transmits between humans only under very specific circumstances, requiring close, prolonged contact and direct exposure to respiratory secretions.
— Nancy Sandoval, infectious disease specialist and vice president of the Pan-American Association of Infectology
Hantavirus mortality from cardiopulmonary syndrome ranges between 35 and 50 percent, making it far more lethal than COVID-19 despite being much less contagious.
— Iris Cazali, infectious disease physician and head of infectious disease unit at Hospital Roosevelt
The Hearth Conversation Another angle on the story
Inventor

Why is everyone suddenly talking about hantavirus now if it's been around since the 1990s?

Model

The Antarctic cruise ship outbreak brought it into the news cycle, but honestly, the virus hasn't changed. What's different is that we're seeing human-to-human transmission documented in a way that makes people nervous. Three deaths on a ship gets attention in a way that scattered rodent-to-human cases don't.

Inventor

So should people actually be worried about a pandemic?

Model

No. The WHO was clear on that. This variant requires sustained, close contact with respiratory secretions. You can't catch it walking past someone in a grocery store. It's not airborne in the way we think of flu or COVID. The real danger is for people in very specific situations—healthcare workers treating patients, family members providing care, people in close quarters like that ship.

Inventor

But the mortality rate sounds terrifying—up to 50 percent?

Model

It is high. That's the paradox of hantavirus. It's not contagious, but when it does infect you, your odds are grim. COVID was the opposite—incredibly contagious, but most people survived. Hantavirus is rare but brutal.

Inventor

What happens if you get it?

Model

You feel like you have the flu for three to five days. Then your lungs start to fail. By that point, doctors can only support you—oxygen, fluids, hoping your body fights it off. There's no drug that kills the virus. No vaccine to prevent it. That's the real problem.

Inventor

How do you even know you have it if it looks like the flu?

Model

You don't, not at first. That's why early diagnosis matters so much. If a doctor knows to test for it, they can start monitoring you closely before things get critical. But if you think it's just a cold and stay home, you might not seek help until you're struggling to breathe.

Inventor

Is there anything people can actually do to protect themselves?

Model

Avoid rodents and their droppings—that's where the virus lives. If you're around someone confirmed to have it, maintain distance and be careful with their respiratory secretions. Beyond that, the protection is mostly in the hands of public health systems catching cases early and isolating patients properly.

Contact Us FAQ